Background {#S0001}
==========

Exposure to androgens can have a powerful effect on a developing female fetus. In humans, placental aromatase deficiency or congenital adrenal hyperplasia can expose the fetus to excess endogenous androgens.^[1](#CIT0001)-5^ In the case of gestational hyperandrogenemia, polycystic ovary syndrome (PCOS), gestational luteoma^[6](#CIT0006)^, or hyperreactio luteinalis,^[7](#CIT0007)^ the fetus may also be exposed to high levels of testosterone from the maternal circulation.^[8](#CIT0008),[9](#CIT0009)^ Hyperandrogenism during pregnancy causes fetal virilization,^[10](#CIT0010),[11](#CIT0011)^ intrauterine growth restriction,^[12](#CIT0012)^ and low birth weight.^[13](#CIT0013)^ These prenatal complications positively correlate with the development in adulthood of hyperinsulinemia^[14](#CIT0014),[15](#CIT0015)^ and metabolic disorders such as obesity,^[16](#CIT0016),[17](#CIT0017)^ hypertension,^[18](#CIT0018)^ and PCOS.^[19](#CIT0019),[20](#CIT0020)^ Similar findings of obesity, hyperleptinemia,^[21](#CIT0021)^ and hyperinsulinemia (19) have been shown in rats and other animals exposed to excess androgens *in utero*.^[22](#CIT0022)^

In rats, gestational days 10--20 are the equivalent of the second trimester of human pregnancy.^[23](#CIT0023),[24](#CIT0024)^ During this period, testosterone peaks between days 17--19.^[25](#CIT0025),[26](#CIT0026)^ Excess prenatal androgens (PNA) during this period induce a hypertensive phenotype in adulthood that is characterized by impaired blood flow in the vascular endothelium^[12](#CIT0012)^, increased blood volume^[27](#CIT0027)^, and increased blood pressure in adult females and males.^[28](#CIT0028),[29](#CIT0029)^ However, the mechanism by which androgens induce this hypertension is not clear. Interestingly, studies of microbial transplantation have demonstrated that the microbiome affects blood pressure.^[30](#CIT0030)^

The microbiome exhibits alterations in PCOS patients and in animal models of excess androgens. Recent studies have found that the profiles of bacterial abundance exhibit similarities between the orders *Clostridales* and *Bacteroidales*.^[22](#CIT0022),[31](#CIT0031),[32](#CIT0032)^ Obese and non-obese women with PCOS had enriched Bacteroidetes and a decreased abundance of *Akkermansia* (of the phylum *Verrucomicrobia*), *Alistipes, Corprococcus*, and *Ruminococcus*.^[33](#CIT0033)^ *Akkermansia* prevalence decreased in diet-induced obesity rats and was inversely correlated with peripheral inflammation in adipose tissue.^[34](#CIT0034)^ *Alistipes*, a bile acid-tolerant bacteria from the genus Bacteroidetes, was decreased in letrozole-treated PCOS mice. In addition, abundance of *Alistipes* positively correlated with fecal levels of short-chain fatty acids (SCFAs)^[35](#CIT0035)−37^, which are thought to reduce obesity and insulin resistance.^[38](#CIT0038),[39](#CIT0039)^ Finally, a decrease in bacteria of the genus *Coprococcus* and *Ruminococcus* were both associated with activation of the hypothalamus-pituitary-adrenal axis and stress-induced depression.^[40](#CIT0040),[41](#CIT0041)^

Recent evidence also suggests that these microbial alterations may drive some of the metabolic derangements associated with PCOS. In an aromatase inhibitor-induced PCOS model, fecal microbial transplant from control animals alleviated symptoms associated with androgenization such as acyclicity, weight gain, and hyperleptinemia in adult rats.^[42](#CIT0042)^ Therefore, understanding the origins of dysbiosis in PCOS may be crucial to preventing and treating this disorder.

How and when the changes in the microbiota occur in hyperandrogenemic states is currently unknown. Previous studies have found that colonization of the gut microbiota begins *in utero*^[43](#CIT0043)^, although growth of bacterial populations that dominate during adulthood begins within a few days after birth.^[44](#CIT0044)^ Further bacterial divergence occurs after puberty, suggesting that hormonal milieu can influence the microbiome. Interestingly, microbial transplantation of male cecum gut flora to females increases serum testosterone levels in both sham and ovariectomized females.^[45](#CIT0045)^ Based on these accumulated findings, we hypothesize that the hypertension seen in PCOS has early origins in dysbiosis caused by *in utero* exposure to androgen excess. As a first step to testing this hypothesis, we examined whether *in utero* exposure to maternal hyperandrogenemia can persistently alter the microbiome of female rat offspring and lead to hypertension in adulthood.

Materials and methods {#S0002}
=====================

Animals {#S0002-S2001}
-------

Male and female Wistar rats (approximately 11--12 weeks of age) were purchased from Charles River Laboratories and housed within the Department of Laboratory Animal Resources Facility of the University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, USA. The animals were on a 12-hr light-dark room schedule and fed *ad libitum*. Female rats were paired with males for two days and separated. Pregnancy was determined by identification of a vaginal plug; that day was designated gestational day 1. The method for prenatal androgen exposure model is described in previous studies.^[20](#CIT0020)^ Briefly, pregnant dams were subcutaneously injected on gestational day 20 under isoflurane with 5mg/kg of body weight with testosterone cypionate (Sigma-Aldrich) in sesame oil or vehicle (sesame oil only). A schematic of the experimental design and animal timeline can be found in [Fig. 1](#F0001). Only female offspring were used for metabolic, cardiovascular, and gut microbiota profile studies. 10.1080/19490976.2018.1441664-F0001Figure 1.Schematic of Experimental Design and Animal Timeline. The animals were separated into two experimental cohorts: cardiovascular and fertility. The cardiovascular cohort experiments were performed from PND 120 to PND 240. Metabolic phenotype includes monthly body weight measurements, fecal sample collection at PND 120 (VEH = 10, PNA = 10), insulin tolerance tests (ITT), and glucose tolerance tests (GTT) (VEH = 12, PNA = 10). Cardiovascular function included Radiotelemetry performed at PND 120 (VEH = 12, PNA = 10), mRNA of the left ventricle of the heart at PND 240 and cardiac histology for assessment of cardiac hypertrophy (VEH = 4, PNA = 4). Renal function included serum and urine assays performed at PND 180 (VEH = 10, PNA = 10). The fertility cohort experiments were performed at PND 120 and PND 180. These experiments included ovarian histology at PND 120 and serum hormone analysis of testosterone (T), luteinizing hormone (LH), and follicle-stimulating hormone (FSH) (VEH = 12, PNA = 10). At PND 180, serum was collected for hormone levels of estradiol (E2), vaginal cytology was collected for assessment of estrus cycles (VEH = 12, PNA = 10). Finally, fertility tests were performed to determine pregnancy rates (VEH = 14, PNA = 8).

Metabolic phenotype assessment {#S0002-S2002}
------------------------------

Glucose tolerance tests (GTT) and Insulin tolerance tests (ITT) were performed at PND120 (VEH, n = 7; PNA, n = 7) as previously described.^[46](#CIT0046),[47](#CIT0047)^ Body weight was measured monthly from PND120 to PND240 (VEH, n = 12; PNA, n = 10).

Cardiac histology {#S0002-S2003}
-----------------

For animals used in cardiac histology and gene expression analyses, sacrifice occurred at PND 240 (VEH, n = 4; PNA, n = 4). Hearts were removed and weighed immediately after sacrifice. The heart was then cut on the short-axis exposing the right ventricle, left ventricle, and papillary muscles and then placed into 10% formalin for 24 hours and 70% ethanol before embedding into paraffin blocks and sectioning at a thickness of 5--7 microns. The sections were then stained with hematoxylin, eosin, and Masson\'s Trichrome. All photographs were taken at 4X magnification with a Bio-Tek Cytation 5 automated microscope (Bio-Tek, Winooski, Vermont, USA) provided by The University of Toledo Advanced Microscopy & Imaging Center (Toledo, Ohio, USA). Quantitation was performed using Image J Image Processing and Analysis.^[48](#CIT0048)^

Radiotelemetry {#S0002-S2004}
--------------

Radiotelemetry transmitter implantation surgeries were performed on PND 120 (VEH, n = 12; PNA, n = 10) female rats as previously described.^[49](#CIT0049),[50](#CIT0050)^ Briefly, the animals were surgically implanted with a radiotelemetry transmitter (Data Sciences International, St. Paul, Minnesota, USA) through the femoral artery. The device was further advanced through to the lower abdominal aorta. The animals were left undisturbed for four days in singly-housed cages before data collection began. Systolic blood pressure, diastolic blood pressure, mean arterial pressure, and heart rate were collected using a moving average every hour for 40 hours.

Hormone analysis {#S0002-S2005}
----------------

Serum was collected from PND120 animals for hormone level analysis by testosterone ELISA (Calbiotech, El Cajon, California, USA, \#TE187S-100) and PND180 animals for hormone level analysis of estradiol (Calbiotech, El Cajon, California, USA, \#ES180S-100) as previously described.^[51](#CIT0051)^ Follicle stimulating hormone and luteinizing hormone were measured in serum at PND180 using the Millipore Pituitary Panel Multiplex kit by The Ligand Assay & Analysis Core of the Center for Research in Reproduction at The University of Virginia School of Medicine.

Fertility assessment {#S0002-S2006}
--------------------

Vehicle and PNA animals were paired with males for four days and separated. The sight of a vaginal plug was designated Gestational Day 1. After 13--15 days of gestation, pregnancy was confirmed by palpation of abdominal region of pregnant dams. Animals were allowed to give birth and the pups were counted and sacrificed. Successful pregnancy was defined by the delivery of pups while unsuccessful/failed pregnancies were defined by the sighting of a vaginal plug but no presence of fetal pups at gestational day 13--15 with palpation or no delivery after 23--25 days of gestation.

Quantitative RT-PCR (qRT-PCR) {#S0002-S2007}
-----------------------------

Approximately 15 mg of frozen left ventricle, ovarian tissue, inguinal white adipose tissue, and interscapular brown adipose tissue were separately homogenized in Trizol Lysis Reagent with the Qiagen TissueLyserLT. RNA was extracted using the Qiagen RNeasy Mini Kit and nucleic acid concentration was quantified with the NanoDrop 2000 spectrophotometer (Thermo Fisher Scientific, Wilmington, DE). cDNA was synthesized with the High-Capacity cDNA Reverse Transcription Kit (Cat No. \#: 4368814, Applied Biosystems). The following thermal-cycling settings were used: Step 1: 25°C for 10 minutes, Step 2: 37°C for 120 minutes, Step 3: 85°C for 5 minutes, and Step 4: 4°C for no more than 1 hour. After thermal-cycling, the sample was diluted with 80 µL of RNAse-Free dH~2~O and frozen at −20°C until further analysis with qRT-PCR. PCR amplification of cDNA was performed by quantitative RT-PCR with the TrueAmp SYBR Green qPCR SuperMix (Smart Bioscience, Maumee, OH). The sequences of primers used for qRT-PCR experiments are listed in [Table 1](#T0001).

Fecal sample collection {#S0002-S2008}
-----------------------

Fresh fecal samples were collected at PND240 and stored in −80°C.

DNA Extraction and Quantification {#S0002-S2009}
---------------------------------

Fecal samples (n = 20) were shipped to Wright Labs, LLC. Nucleic acid extractions were performed on approximately 0.25 g of each sample using a MoBio Powerfecal DNA Isolation kit following the manufacturer\'s instructions (MoBio Carlsbad, California, USA). The vortexing step was performed using the Disruptor Genie cell disruptor (Scientific Industries, Bohemia, NY). The resulting genomic DNA was eluted in 50 µl of 10 mM Tris. The Qubit 2.0 (Invitrogen) Fluorometer according to the Protocol of the dsDNA High Sensitivity option was then utilized to quantify total DNA.

16S rRNA Gene PCR Amplification {#S0002-S2010}
-------------------------------

Illumina iTag Polymerase Chain Reactions (PCR) were performed at a total volume of 25 μL for each sample and contained final concentrations of 1X PCR buffer, 0.8 mM dNTP\'s, 0.625 U Taq, 0.2 μM 515F forward primer, 0.2 μM Illumina 806R reverse barcoded primer and ∼10 ng of template DNA per reaction. PCR was carried out on a MJ Research PTC-200 thermocycler (Bio-Rad, Hercules, California, USA) using the following cycling conditions: 98 °C for 3 min; 35 cycles of 98 °C for 1 min, 55 °C for 40 s, and 72 °C for 1 min; 72 °C for 10 min; and kept at 4 °C. PCR products were visualized on a 1% CYBRsafe E-gel.^[62](#CIT0062)^

Library purification, verification, and sequencing {#S0002-S2011}
--------------------------------------------------

Pooled PCR products were gel purified using the Qiagen Gel Purification Kit (Qiagen, Frederick, Maryland, USA). Clean PCR products were quantified using the Qubit 2.0 Fluorometer (Life Technologies, Carlsbad, CA), and samples were combined in equimolar amounts. Prior to submission for sequencing, libraries were quality checked using the 2100 Bioanalyzer DNA 1000 chip (Agilent Technologies, Santa Clara, CA). Pooled libraries were stored at −20 °C until they were shipped on dry ice to the California State University (North Ridge, CA) for sequencing. Library pools were size verified using the Fragment Analyzer CE (Advanced Analytical Technologies Inc., Ames IA) and quantified using the Qubit High Sensitivity dsDNA kit (Life Technologies, Carlsbad, CA). After dilution to a final concentration of 1 nM and a 10% spike of PhiX V3 library (Illumina, San Diego CA), pools were denatured for 5 minutes in an equal volume of 0.1 N NaOH, then further diluted to 12 pM in Illumina\'s HT1 buffer. The denatured and PhiX-spiked 12 pM pool was loaded on an Illumina MiSeq V2 500 cycle kit cassette with 16S rRNA library sequencing primers and set for 250 base, paired-end reads.

Quality filtering and operational taxonomic unit (OTU) selection {#S0002-S2012}
----------------------------------------------------------------

Paired-end sequences were trimmed at a length of 250 bp and quality filtered at an expected error of less than 0.5% using USEARCH v7.^[63](#CIT0063)^ After quality filtering, reads were analyzed using the QIIME 1.9.0 software package (\[62, 64\]. Chimeric sequences were identified using USEARCH61.^[65](#CIT0065)^ A total of 680,091 sequences were obtained after quality filtering and chimera checking. Open reference operational taxonomic units (OTUs) were picked using the USEARCH61 algorithm, and taxonomy assignment was performed using the Greengenes 16S rRNA gene database (13--5 release, 97%).^[66](#CIT0066)^ Assigned taxonomy were organized into a BIOM formatted OTU table and summarized within QIIME 1.9.0.

Alpha diversity analysis {#S0002-S2013}
------------------------

Alpha diversity plots were generated within the Phyloseq sequence analysis package using a rarified OTU table.^[67](#CIT0067)^ Rarefaction was conducted on sequences across all samples to a maximum depth of 20,923 sequences. Alpha diversities were then collated and plotted using observed species richness.

Beta diversity analysis {#S0002-S2014}
-----------------------

Principal coordinates analyses (PCoA) plots and ANOSIM tests for significance were generated from a weighted UniFrac distance matrix made within QIIME 1.9.0 from a CSS normalized OTU table.^[68](#CIT0068)^

Taxonomic comparisons {#S0002-S2015}
---------------------

Assigned taxonomy were organized into a BIOM formatted OTU table and were summarized within Qiime-1.

LefSe analysis of enriched taxa {#S0002-S2016}
-------------------------------

Relative abundances of taxa were multiplied by 1 million and formatted.^[69](#CIT0069)^ Comparisons were made with "Sample Type" as the main categorical variable ("Class"). Alpha levels of 0.01 were used for both the Kruskal--Wallis and pairwise Wilcoxon tests. Linear Discriminant Analysis (LDA) scores greater than 3.0 are displayed.

Predictive functional analysis {#S0002-S2017}
------------------------------

PICRUSt functional predictions were generated from a closed-reference OTU table generated within QIIME-1.9.0. Relative abundances of predicted functional genes were multiplied by 1 million and formatted.^[69](#CIT0069)^ Comparisons were made with "Group" as the main categorical variable ("Class"). Alpha levels of 0.05 were used for both the Kruskal--Wallis and pairwise Wilcoxon tests. Linear Discriminant Analysis (LDA) scores greater than 2.0 are displayed.

Principal coordinates analysis (PCoA) plots {#S0002-S2018}
-------------------------------------------

Principal Coordinates Analysis (PCoA) plots were used to visualize differences in weighted Unifrac distances of fecal samples from PNA (P) and VEH (V) cohorts. Points clustered more closely together are more similar in terms of phylogenetic distance, whereas points that are distant from each other are phylogenetically distinct. Samples cluster significantly based on their specific grouping (ANOSIM p = 0.002).

Relative abundance graphs {#S0002-S2019}
-------------------------

Taxonomic relative abundance graphs were prepared using operational taxonomic units and classification of microbiome populations into respective taxonomic phyla, order, family, and genus. Graphs were then prepared in GraphPad Prism 7 using relative abundance percentage of bacteria within control and prenatal androgen (PNA) groups.

Statistical analysis {#S0002-S2020}
--------------------

All graphs were created with GraphPad Prism 7 (GraphPad Software, San Diego, CA). Data is reported as the mean and standard error of the mean. Data were analyzed using student\'s t-test for statistical significance and reported as follows: *p* ≤ 0.05 (\*), ≤ 0.01 (\*\*), and ≤ 0.001 (\*\*\*).

Results {#S0003}
=======

We first tested whether PNA treatment induced metabolic dysfunction in adulthood. Between PND 120 to PND 240, the body weight of the PNA animals was significantly higher than in control animals ([Fig. 2a](#F0002)). After observing increased body weight, we investigated glucose and insulin sensitivity with glucose (GTT) and insulin tolerance tests (ITT). Insulin tolerance testing (ITT) revealed higher plasma glucose levels at 30 minutes and 60 minutes after intraperitoneal injection of insulin in the PNA animals, suggesting some degree of insulin resistance ([Fig. 2b](#F0002)). Glucose clearance was not impaired in the PNA rats ([Fig. 2c](#F0002)). However, the increased body weight within the PNA animal group led us to question whether there was differential mRNA expression of adipokines within the peripheral adipose tissue depots of the interscapular brown adipose tissue (iBAT) and inguinal white adipose tissue (iWAT) ([Fig. 2f--k](#F0002)). We found significantly increased mRNA expression of adipocyte binding protein 2 (ap2), adiponectin (AdipoQ), and leptin (Lep) within the iWAT of the PNA animals, but similar expression of the markers within iBAT. 10.1080/19490976.2018.1441664-F0002Figure 2.Metabolic Assessment: Body Composition, Glucose and Insulin Tolerance Tests, mRNA Expression of Adipokines within Adipose Tissue. (a) Body weight was measured from PND 120 to PND 240. (b) Glucose tolerance test (GTT) was performed at PND150 with intraperitoneal injection (IP) of dextrose and plasma glucose levels were recorded for time 0 to 120 minutes. (c) Insulin tolerance test (ITT) was performed at PND150 with IP injection of insulin and plasma glucose levels were recorded for time 0 to 90 minutes. (d) Area under the curve (AUC) for GTT was calculated for all plasma glucose levels between 0--120 minutes (e) Area under the curve (AUC) for ITT was calculated for all plasma glucose levels between 0--90 minutes. Bars represent mean and lines represent standard error (SEM); (f) iBAT aP2 mRNA expression, g) iWAT aP2 mRNA expression, (h) ibAT AdipoQ mRNA expression, (i) iWAT AdipoQ mRNA expression, (j) iBAT Lep mRNA expression, (k) iWAT Lep mRNA expression. The tissue was dissected from sacrificed animals at PND120 and the sample size was n = 6--7 animals per group (VEH or PNA). Bars represent means and the lines represent the standard error of the mean (SEM). Symbols in either black (VEH) or red (PNA) represent the distribution of relative expression (RQ) values within each group. All genes were normalized to the RQ of 18S.

We next tested whether PNA treatment induced reproductive dysfunction in adulthood. We found that early androgenization reduced the number of primordial, preovulatory, and the overall number of follicles within the ovaries of the PNA animals ([Fig. 3a--c](#F0003)). Over a period of nine days, the PNA animals spent a significantly longer duration within the metestrus/diestrus stage of the estrus cycle ([Fig. 3d--e](#F0003)) and a shorter period in estrus ([Fig. 3f](#F0003)). There were no differences in time spent in proestrus. However, the PNA animals had a significantly lower pregnancy success rate after being paired with males for four days. Approximately 13% (VEH, n = 14; PNA, n = 8) of the PNA animals became pregnant compared to 57% of the vehicle animals ([Fig. 3g](#F0003)). Previous reports have found altered reproductive hormone levels in this model between PND 75-PND 90.^[20](#CIT0020)^ In our animals, we found no difference in the serum estradiol ([Fig. 3h](#F0003)), testosterone ([Fig. 3i](#F0003)), or FSH levels ([Fig. 3j](#F0003)) of the VEH and PNA animals. Surprisingly, while the ratio of LH to FSH was unaltered, serum LH levels were significantly lower in the PNA animals ([Fig. 3k](#F0003)). 10.1080/19490976.2018.1441664-F0003Figure 3.Fertility and Serum Hormone Analysis. (a) Hematoxylin and eosin stained ovary of female vehicle rat at PND 120; (b) Hematoxylin and eosin stained ovary of female PNA rat at PND 120; (c) Total follicle count of primordial, primary, preantral, antral, preovulatory, corpora lutea, and total follicle count; (d) Estrous cycle data for nine consecutive days of vaginal smearing of vehicle (n = 12) rats; (e) Estrous cycle data for nine consecutive days of vaginal smearing of and prenatal androgen rats (n = 11); (f) Duration of estrus cycle and number of days spent in each stage for PNA animals compared to vehicle; (g) Pregnancy success rates for vehicle (n = 14) and PNA (n = 8) rats at PND 180; (h) Serum beta-estradiol levels for VEH and PNA animals measured in picograms per milliliter at PND 180; (i) Serum testosterone levels for VEH and PNA animals measured in nanograms per milliliter at PND 120; (j) Serum follicle stimulating hormone (FSH) levels for VEH and PNA animals measured in nanograms per milliliter in animals at PND 180; (k) Serum luteinizing hormone (LH) levels for VEH and PNA animals measured in nanograms per milliliter in animals at PND 180; and (l) LH:FSH ratio measured for animals at PND 180.

Given reports of increased hypertension rates in obese women with PCOS^[18](#CIT0018),[70](#CIT0070)^, we examined blood pressure in this model. Telemetry revealed that blood pressure was increased in PNA animals. Overall, systolic, diastolic and mean arterial blood pressures were higher in the PNA rats, particularly at night ([Fig. 4a--c](#F0004)). Interestingly, heart rate was decreased in both day and night recording obtained from the PNA rats compared to the VEH group ([Fig 4d](#F0004)). The BPM was significantly decreased between hour 8--12, and from hour 20--28 for the PNA rats. The heart rate was 440 ± 31 BPM for the vehicle group and 406 ± 25 BPM ([Fig. 4d](#F0004)). Mean locomotor activity was also significantly reduced within the PNA animal group ([Fig. 4e](#F0004)). Despite the lower heart rates, the increases observed in blood pressure in the PNA group are notable. The overall increased systolic and diastolic blood pressure places the PNA animals in the range of uncomplicated stage I hypertension (between 140/90 to 150/99 mmHg).^[71](#CIT0071),[72](#CIT0072)^ 10.1080/19490976.2018.1441664-F0004Figure 4.Radiotelemetry Blood Pressure, Heart Rate, and Locomotor Activity. Radiotelemetry analysis was performed for moving averages every hour for 28 hours with standard error calculated for each hour. The shaded areas on the graph represent night hours. (a) Systolic blood pressure (SBP), (b) diastolic blood pressure (DBP), (c) Mean arterial pressure (MAP), (d) heart rate (BPM), and (e) locomotor activity.

PNA animals showed significantly increased thickness of left ventricle (LV) anterior muscle wall ([Fig. 5a](#F0005)), posterior muscle wall ([Fig. 5b](#F0005)), and decreased left ventricle CSA ([Fig. 5c](#F0005)). There were no differences observed in the wall thickness of the right ventricle between the inner endocardium and the outer epicardium ([Fig. 5d--e](#F0005)). Masson\'s Trichrome staining of the short axis view of the rat hearts with angulation revealed the right ventricle, left ventricle, and papillary muscles ([Fig. 5g](#F0005), [**5**h](#F0005)) which allowed for measurements of the wall thickness and cross-sectional area. Next, we performed quantitative RT-PCR experiments to test for mRNA expression of sex steroid receptors and biomarkers of cardiovascular health to confirm if there was differential expression of markers associated with the development of cardiac hypertrophy and hypertension.^[56](#CIT0056),[60](#CIT0060),[73](#CIT0073),[74](#CIT0074)^ Androgen receptor ([Fig. 6a](#F0006)) mRNA expression was upregulated in the left ventricle of the PNA hearts while ERα and ERβ expression ([Fig. 6b--c](#F0006)) was not significantly different in expression levels. ANP and BNP were not increased in the left ventricle of the PNA animals ([Fig. 6d--e](#F0006)). However, mRNA expression of renin (REN) was increased in the left ventricle of PNA animals ([Fig. 6f](#F0006)). 10.1080/19490976.2018.1441664-F0005Figure 5.Cardiac morphology and gross anatomical measurements. (a) left ventricle (LV) anterior muscle wall; (b) LV posterior muscle wall; (c) left ventricle cross sectional area (CSA); (d) intraventricular septum (e) right ventricle (RV) inner endocardium to outer epicardium measurement; (f) right ventricle cross sectional area (CSA); (g) Masson\'s trichrome stain of short-axis cut with angulation to expose left ventricle papillary muscles and apex of right ventricle (RV) of VEH female rat; (h) Masson\'s trichrome stain of short-axis cut of heart with angulation to expose left ventricle papillary muscles and apex of right ventricle of PNA female rat. 10.1080/19490976.2018.1441664-F0006Figure 6.mRNA Expression of Sex Steroid Receptors, Cardiac Hypertrophy Markers, and Renin within Left Ventricle (LV) of the Heart. (a) AR, androgen receptor mRNA expression; (b) ERα, estrogen receptor alpha mRNA expression; (c) ERβ, estrogen receptor beta mRNA expression; (d) ANP, atrial naturetic protein mRNA expression; (e) BNP, B-type (brain) naturetic protein mRNA expression; (f) Ren, renin mRNA expression. All genes were normalized to 18S expression. All bars represent the mean values of relative expression (RQ) and lines represent standard error of the mean.

Kidney weight, urine output, urine microalbumin levels were similar between vehicle and PNA animals ([Fig. 7a--c](#F0007)). However, we found decreased creatinine levels in urine ([Fig. 7d](#F0007)). Measurement of the microalbumin to creatinine ratio (p = 0.070), and serum cystatin C (p = 0.057) appeared higher in the PNA animals, but did not reach significance ([Fig. 7e--f](#F0007)). These findings suggested an early-stage, impaired glomerular filtration. 10.1080/19490976.2018.1441664-F0007Figure 7.Renal Function Assessment of Serum Cystatin C and Urine Microalbumin and Creatinine. (a) paired kidney weight was measured immediately after dissection. (b) urine output was calculated from 24-hour urine volume in milliliters divided by body weight in grams, divided by 24-hours. (c) urine creatinine was measured from 24-hour fasting urine. (d) microalbumin was measured from 24-hour fasting urine. (e) microalbumin/creatinine ratio. (f) cystatin C concentration was measured using serum collected from PND180 animals.

Having established cardiometabolic dysfunction in our model, we looked for evidence of microbiome alterations using fecal samples obtained at PND 180. A profile of the fecal microbiota was produced at the phyla, order, family, and genus level for over 33,000 sequences found within the vehicle and PNA group after quality filtering of 20,923 to 64,164 sequences per sample. Each sample had a sequencing depth of over 1,000 sequences and were organized into CSS Normalized Operational Taxonomic Unit (OTU) Tables that included known information for kingdom, phylum, class, order, family, and genus. This information was then used to determine the total number of OTUs found within each sample at the various levels of classification and relative abundances was reported in percentages. We found the top 10 most abundant phyla were *Actinobacteria, Bacteroidetes, Firmicutes, Proteobacteria, Verrucomicrobia, Tenericutes, Fusobacteria, Planctomycetes, Nitrospirae*, and *Spirochaetes* (Supplemental Table 1). Bacteria found within the phyla *Verrucomicrobia* (V, 0.38%; P, 8.30%; p = 0.001) *Proteobacteria* (V, 2.63%; P, 5.29%; p = 0.044), and *Planctomycetes* (V, 0.00%; P, 0.06%; p = 0.002) were significantly enriched within the fecal microbiota of the PNA rats. Bacteria found within the phyla Fusobacteria (V, 0.53%; P, 0.26%; p = 0.005) and *Spirochaetes* (V, 0.03%; P, 0.02%; p = 0.042) were significantly decreased while there were no differences found in bacteria at the phylum level for *Firmicutes, Bacteroidetes, Actinobacteria, Tenericutes*, and *Nitrospirae*.

After we determined the most abundant phyla, we focused our subsequent analysis on the relative abundances of bacteria found within *Actinobacteria* ([Fig. 8a](#F0008)), *Bacteroidetes* ([Fig. 8b](#F0008)), *Firmicutes* ([Fig. 8c](#F0008)), *Proteobacteria* ([Fig. 8d](#F0008)), *Verrucomicrobia* ([Fig. 8e](#F0008)). 10.1080/19490976.2018.1441664-F0008Figure 8.Relative abundance of bacteria within the most abundance phylum: *Actinobacteria, Bacteroidetes, Firmicutes, Proteobacteria*, and *Verrucomicrobia*. Relative abundance of bacteria at the phylum, order, family and genera levels were determined using operational taxonomic units for each. The graphs represent the percentages for the relative abundance of bacteria from the total OTU of each phylum, order, family, or genera.

Actinobacteria {#S0003-S2001}
--------------

Bifidobacteriales was the only order that was significantly reduced within the PNA animals ([Fig. 8a](#F0008), Supplementary Table 2). At the family level, bacteria from *Yaniellaceae, Geodermatophilaceae, Microbacteriaceae, Nakamurellaceae, Corynebacteriaceae, Promicromonosporaceae*, and *Nocardiaceae* were significantly enriched within the PNA animal fecal microbiota. Bacteria from *Brevibacteriaceae* and *Dermabacteraceae* were significantly decreased within the PNA fecal microbiota. At the genus level, bacteria from *Yaniella, Rathayibacter, Modestobacter, Microbispora, Arthrobacter, Frigoribacterium, Cellulomonas, Aeromicrobium, Xylanimicrobium*, and *Rhodococcus* were significantly enriched within the PNA animal fecal microbiota. Bacteria from *Bifidobacterium, Corynebacterium, Brevibacterium, Brachybacterium, Adlercreutzia*, and *Rothia* were significantly decreased within the PNA fecal microbiota.

Bacteroidetes {#S0003-S2002}
-------------

There were no significant differences observed within the relative abundance of bacteria from the orders *Bacteroidales, Flavobacteriales, Cytophagales, Sphingobacteriales*, and *Saprospirales* in the PNA animal fecal microbiota profile ([Fig. 8b](#F0008), Supplementary Table 3). We then further analyzed the individual families within each order to determine if there was differential abundance of bacteria. We found that at the family level, bacteria from *Rikenellaceae, Paraprevotellaceae*, and an unknown family within Bacteroidetes were significantly enriched within the PNA group fecal microbiota. Bacteria from *Bacteroidaceae, Odoribacteraceae*, and *S24-7* were significantly decreased. At the genus level, bacteria from *Rikenella, Paraprevotella*, and *Tannerella* were significantly enriched within the PNA animal fecal microbiota. Bacteria from *Bacteroides, Odoribacter*, and *Parabacteroides* were significantly decreased within the PNA fecal microbiota.

Firmicutes {#S0003-S2003}
----------

At the order level, bacteria from *Thermoanaerobacterales* were significantly enriched and *Erysipelotrichales* and *Turicibacterales* were significantly decreased within the PNA fecal microbiota ([Fig. 8c](#F0008), Supplementary Table 4). At the family level, bacteria from *Peptococcaceae, Eubacteriaceae, Carnobacteriaceae, Tissierellaceae, Streptococcaceae, Veillonellaceae, Coprobacillus*, and *Leuconostocaceae* were significantly enriched within the PNA animal fecal microbiota. Bacteria from *Ruminococcaceae, Lachnospiraceae, Clostridiaceae, Erysipelotrichaceae, Dehalobacteriaceae, Lactobacillaceae*, and *Mogibacteriaceae* were significantly decreased within the PNA fecal microbiota. At the genus level, bacteria from *RC4-4, Anaerofustis, Faecalibacterium, Blautia, Granulicatella, Roseburia, Jeotgalicoccus, Peptoniphilus, Veillonella, Streptococcus, Oribacterium, Sporosarcina, Lactococcus, Selenomonas, Weissella*, and *Exiguobacterium* were significantly enriched within the PNA animal fecal microbiota. Bacteria from *Ruminococcus, Staphylococcus, Clostridium, Facklamia, Dehalobacterium, Lactobacillus*, and *Dorea* were significantly decreased within the PNA fecal microbiota.

Proteobacteria {#S0003-S2004}
--------------

At the order level, bacteria from *Chromatiales, Rhodospirillales, Sphingomonadales, Rhodobacterales, Caulobacterales, BD7-3, Rickettsiales, MIZ46, Legionellales, Alteromonadales*, and an unknown order within the phylum Proteobacteria were significantly enriched within the PNA animal fecal microbiota ([Fig. 8d](#F0008), Supplementary Table 5). Bacteria from *Burkholderiales, Pseudomonadales, Enterobacteriales*, and *Neisseriales* were significantly decreased within the PNA fecal microbiota. At the family level, bacteria from *Moraxellaceae, Rhodobacteraceae, Sphingomonadaceae, Caulobacteraceae, Comamonadaceae, Sinobacteraceae, Rhodospirillaceae, Piscirickettsiaceae, Hyphomicrobiaceae*, and *Coxiellaceae* were significantly enriched within the PNA animal fecal microbiota. Bacteria from *Enterobacteriaceae* and *Neisseriaceae* were significantly decreased within the PNA fecal microbiota. At the genus level, bacteria from *Sphingobium, Kingella, Mycoplana, Aggregatibacter, Steroidobacter, Methylibium, Buchnera, Bilophila*, and *Arcobacter* were significantly enriched within the PNA animal fecal microbiota. Bacteria from *Sutterella, Neisseria*, and *Pseudomonas* were significantly decreased within the PNA fecal microbiota.

Verrucomicrobia {#S0003-S2005}
---------------

At the order level, bacteria from *Verrucomicrobiales* were significantly enriched within the PNA animal fecal microbiota ([Fig. 8e](#F0008), Supplementary Table 6). At the family level, bacteria from *Verrucomicrobiaceae* were significantly enriched within the PNA animal fecal microbiota. At the genus level, bacteria from *Prosthecobacter* were significantly enriched within the PNA animal fecal microbiota. Bacteria from *Akkermansia* were significantly decreased within the PNA fecal microbiota.

As the next step towards understanding whether dysbiosis contributes to the PCOS-like phenotype of these animals, we analyzed the potential function of bacteria found in their gut (Supplemental Table 7). A predictive function analysis associates microbiome bacteria and bacterial enzyme metabolites with a general function or disease. The values for each group are the average operation taxonomic units (OTU) and are derived from different bacteria classified into order, family, or genus based on their similarity.^[75](#CIT0075)^ The predictive functional analysis revealed that the dysbiosis seen in prenatal androgen exposed animals was associated with adipokine production, prostaglandin activity, gastric mucosal secretion, and signaling pathways of growth factors recruited for cell proliferation and activity of epithelial cells throughout the gastrointestinal tract. PNA animals had an increased number of bacteria associated with overall amino acid (AA) metabolism, especially increased beta-alanine, arginine, proline, lysine, phenylalanine, and tryptophan metabolism.

Alpha diversity analysis (Supplemental Figure 2a) was performed utilizing Phyloseq sequence analysis on the samples to determine the species richness and evenness, or number of bacterial species within the fecal sample and the distribution of bacterial taxonomy, respectively.^[76](#CIT0076)^ Alpha diversity revealed that the PNA animals had a higher average of species richness. Beta diversity analysis (Supplemental Figure 2b) was performed utilizing principal coordinate analyses plots to illustrate the phylogenetic distance of the bacterial communities of the fecal samples. The beta diversity analysis revealed that both cohorts had distinct clustering, however the PNA animal samples were further apart.

Discussion {#S0004}
==========

Androgen excess disorders like PCOS affect between 5--20% of reproductive age women worldwide.^[42](#CIT0042),[77](#CIT0077)^ PCOS has been linked to metabolic syndrome particularly insulin resistance^[78](#CIT0078)^ and hypertension.^[79](#CIT0079)−82^ When a pregnant mother with PCOS is subsequently diagnosed with hyperinsulinemia, hypertension, or hyperandrogenemia during pregnancy this increases maternal and fetal morbidity and mortality.^[83](#CIT0083)−85^ The likelihood of developing obstetric complications during pregnancy such as gestational diabetes, preeclampsia, and early termination of pregnancy increase.^[86](#CIT0086)−89^ While the etiology of metabolic derangement in PCOS women and their offspring is not well understood, this study describes a profile of cardiometabolic dysfunction that is associated with gut microbiota dysbiosis in offspring exposed to androgens prenatally.

Exposure to androgens *in utero* can cause reproductive consequences for the female human fetus depending on the extent of the exposure.^[90](#CIT0090),[91](#CIT0091)^ In the male human fetus, testosterone production by the testis is detectable at 9 weeks and peaks between 12 to 14 weeks.^[92](#CIT0092)^ Testosterone (T) levels then fall sharply, so that by the 20^th^ week the fetal serum testosterone is back to sexually indifferent levels. In contrast, the female gonads produce few sex steroids during development. T-levels present up through the 14^th^ week will masculinize the reproductive organs. High levels of T throughout the critical period will masculinize basal LH release during adulthood and eliminate the ability of the GnRH circuitry to generate a preovulatory surge in response to estradiol. T exposure within a narrower window around the normal T peak will masculinize sexual behavior and the brain regions that control it^[94](#CIT0094),[95](#CIT0095)^ In contrast, low doses of T throughout this critical window will have no effect on genitalia, behavior, or adult basal LH release, but will partially impair LH surges.^[96](#CIT0096)^

Our study has shown that prenatal exposure to excess androgens in late gestation negatively impacts metabolic profile into adulthood and impairs fertility likely by suppressing LH release. Early androgenization was sufficient to disrupt insulin sensitivity and increase body weight. PNA rats developed obesity with increased serum glucose levels after ITT, indicating impaired insulin sensitivity. They also showed increased mRNA expression of adipokines within iWAT. The inguinal fat depot of rodents is similar to the gluteofemoral subcutaneous depot in humans and this fat depot is more sensitive to insulin in humans^[97](#CIT0097),[98](#CIT0098)^, however the effect in rodents has been found to be inconclusive. In obese women, there is increased 17β-hydroxysteroid dehydrogenase type 5 activity within subcutaneous fat depots compared to visceral fat depots indicating increased androgen synthesis within subcutaneous depots.^[99](#CIT0099)^ Increased mRNA expression of adipokines within iWAT has also been associated with LPS-induced inflammation and required for healthy adipogenesis after acute inflammation.^[100](#CIT0100)^ However, the release of leptin from white adipose tissue has been associated with increased risk for developing hypertension.^[101](#CIT0101)^ Upregulation of adipokine mRNA in peripheral adipose tissues has been associated with PCOS, obesity, and hyperinsulinemia.^[102](#CIT0102),[103](#CIT0103)^ Future directions for our studies could investigate the synthesis and release of androgens and adipokines into circulation and determine whether this also contributes to hyperandrogenemia or increased risks of cardiovascular disease in women with PCOS and other disorders that fall under metabolic syndrome.

We also found increased blood pressure and reduced heart rate in PNA exposed rats, providing the first evidence in an animal model that early androgenization *in utero* may increase risk of the development of hypertension and disrupt autonomic control of heart rate. We found that androgen receptor within the left ventricle was increased in the PNA animals, however we did not investigate cardiac insulin sensitivity and propose this as a future direction. Reduced insulin sensitivity or upregulated expression of androgen receptor within the heart has been found to impair cardiac function.^[104](#CIT0104),[105](#CIT0105)^ The upregulation of androgen receptor that we observed within the PNA heart may alter the electrophysiology of the cardiomyocytes of the left ventricle by altering expression of receptors involved in the regulation of membrane potential.^[106](#CIT0106),[107](#CIT0107)^ Androgens may promote the development of cardiomyopathy by upregulating potassium channel regulatory subunits and reducing cardiomyocyte repolarization.^[108](#CIT0108),[109](#CIT0109)^ Indeed, the enlarged walls and decreased cross-sectional area of the left ventricle in the PNA animals resembles early-stage concentric cardiac hypertrophy, although mRNA expression of markers of cardiac hypertrophy were unchanged in PNA animals. Support for this possibility is provided by previous studies in which antiandrogenic treatment attenuated cardiac hypertrophy.^[110](#CIT0110),[111](#CIT0111)^

Cystatin C is a low molecular weight protein (MW: 13.3 kDa) from the family of cysteine protease inhibitors that is found in all nucleated cell types including cardiac muscle.^[112](#CIT0112),[113](#CIT0113)^ Cystatin C is freely filtered by the glomeruli, reabsorbed by tubular epithelial cells, and broken down; therefore, increased concentrations of Cystatin C in serum is related to impaired glomerular filtration.^[114](#CIT0114)−116^ It is also associated with increased left ventricular mass, a precursor to cardiac left ventricular hypertrophy (LVH)^[117](#CIT0117)^, which is associated with increased risk of hypertension.^[118](#CIT0118)^ Our findings suggest that the kidneys of PNA animals may have impaired glomerular filtration as evident by increased serum cystatin C.

Models of excess sex steroid hormone synthesis have found that the gut microbiota profile is altered by excess androgens. In letrozole-induced PCOS models, gut microbiota exhibited a deficiency in bacteria from the genera *Clostridium, Lactobacillus, Ruminococcus* but an enrichment of *Prevotella* with no differences observed in bacteria from *Bifidobacterium, Enterococcus*, and *Bacteroides*.^[42](#CIT0042)^ Another letrozole-induced PCOS model displayed an increase in bacteria of the genera *Alistipes, Allobaculum, Blautia*, and *Ruminococcaceae*.^[35](#CIT0035)^ Neonatal exposure to a single-injection of testosterone increased the concentration of *Ruminococcus* and *Coprococcus*---two bacteria involved in bile acid synthesis and found to be increased in the gut of prediabetics.^[22](#CIT0022),[119](#CIT0119)^

In the current study, hypertension within the PNA group was accompanied by dramatic changes in the gut microbiota profile. The fecal microbiota of PNA animals contained higher abundance of bacteria commonly associated with steroid hormone synthesis, including bacteria from the families *Nocardiaceae*^[120](#CIT0120)^ and *Clostridiaceae*.^[121](#CIT0121),[122](#CIT0122)^ In addition, PNA animals have significantly increased abundance of fecal bacteria associated with cardiovascular function including cardiac muscle contraction, proximal tubule bicarbonate reclamation, and the renin-angiotensin (RAS) system. In previous studies of the fecal microbiota of hypertensive rats, *Allobaculum, Aggregatibacter*, and *Sutturela* were enriched however, we found that only *Aggregatibacter* was enriched and *Allobaculum* and *Sutturela* were significantly decreased in relative abundance within the fecal microbiota of the PNA animals; these bacteria are associated with glucose metabolism and the specific role is unknown.^[123](#CIT0123)−125^

We found that the gut microbiota profile resembles the profile of both patients and other animal models of PCOS; specifically the gut of androgenized women and female rats was found to be depleted of bacteria from *Akkermansia, Bacteroides, Lactobacillus, Clostridium*.^[33](#CIT0033),[42](#CIT0042)^ Administration of *Akkermansia* as a probiotic was shown to improve the intestinal barrier of the gut by increasing the expression of mucin 2 within the colon.^[126](#CIT0126)^ A decreased abundance of *Akkermansia* within the colon of PCOS patients and our prenatal androgen model may be associated with impaired mucosal maintenance. After treatment with Metformin, the gut microbiota of patients with PCOS became enriched with *Akkermansia*, bacteria that may be associated with glucose homeostasis.^[127](#CIT0127)^ These gram-negative bacteria are associated with increased production of the bacterial metabolite, lipopolysaccharide (LPS) and induce T cell-mediated immune responses.^[128](#CIT0128)^

PNA animals had an increased number of bacteria associated with biosynthesis and elongation of unsaturated short chain fatty acids (SCFAs), such as acetate, butyrate, and propionate. These metabolites from the fermentation of nondigested carbohydrates are absorbed by colonocytes within the cecum and colon.^[129](#CIT0129)−131^ After absorption, SCFAs are processed in the liver for use in gluconeogenesis and lipogenesis.^[132](#CIT0132)−135^ Interestingly, dietary supplementation with SCFAs has been shown in rodents to promote a switch from lipid synthesis to oxidation and to protect against obesity and insulin resistance.^[38](#CIT0038),[39](#CIT0039)^ Bacteria from the family *Enterobacteriaceae*, particularly *Escherichia coli*, have been associated with increased systemic lipopolysaccharides^[136](#CIT0136)^, increased risk of obesity, inflammation, reduced glomerular filtration rate, increased serum cystatin C and insulin resistance.^[71](#CIT0071),[137](#CIT0137),[138](#CIT0138)^

*Actinobacteria, Bacteroidetes*, and *Firmicutes* were the most abundant phylum of bacteria found within the fecal microbiota of the control and PNA group. In the phylum *Actinobacteria*, bacteria from the families *Coriobacteriaceae, Cellulomonadaceae*, and *Micrococcaceae* share the highest abundance in both the control and PNA groups, however the PNA groups have increased abundance of *Nocardioidaceae*---bacteria that was absent in the vehicle group. Other bacteria families such as *S24-7* and *Odoribacteraceae* from the order Bacteroidales were virtually absent within the PNA group. These two families contain bacteria associated with butyrate-production and are found in low-abundance in sedentary women, hypertensive Dahl salt-sensitive rats, and HFD mice fecal microbiota.^[30](#CIT0030),[139](#CIT0139),[140](#CIT0140)^

Gram-positive bacteria, such as bacteria from the family *Lachnospiraceae*, have been implicated in the development and manifestation of ulcerative colitis.^[141](#CIT0141),[142](#CIT0142)^ When the colonic epithelial barrier is disrupted, a negative immune response is triggered after exposure to *Lachnospiraceae*.^[143](#CIT0143)^ Our study shows a significantly decrease in the OTU of bacteria from *Lachnospiraceae*, but other gram-positive bacteria such as *Peptococcaceae, Eubacteriaceae, Tissierellaceae, Streptococcaceae, Veillonellaceae, Coprobacillus*, and *Leuconostocaceae* were all significantly increased in abundance within the gut microbiota of PNA animals. The role of gram-positive bacteria and the disruption of the colonic epithelial cell permeability will require further investigation to determine which particular bacteria induce peripheral inflammatory responses in tissues such as the heart, brain and adipose.

Further investigation is needed into when PNA treatment alters gut microbial proliferation and whether early exposure to the maternal microbiota plays an important role. The maternal vaginal or gut flora may influence the development of gut microbial colonization. Mothers with hyperandrogenemia may also expose their fetus to high serum testosterone levels that alter the differentiation of gut epithelial cells and regulate their permeability or functionality. In addition, recent studies have shown that maternal antibodies alter postnatal immunity by increasing aryl hydrocarbon receptors for maternal bacterial metabolites.^[144](#CIT0144)^ Additional study is needed into the role of steroidogenesis and gut epithelium function in the developing fetus.

In sum, our study is the first to document hypertension and gut microbiota dysbiosis in a rodent model of prenatal hyperandrogenemia. It also substantiates the powerful and long-lasting effect of sex steroids on microbiome composition and metabolic homeostasis. Understanding the relationship between fetal developmental programming, metabolic dysfunction, and gut microbiota dysbiosis is a critical step in developing potential treatment options or preventative therapies for the offspring of women who exhibit hyperandrogenemia during pregnancy. 10.1080/19490976.2018.1441664-T0001Table 1.Quantitative real-time PCR primers.GeneForward (5′\>3′)Reverse (5′\>3′)Reference18SGAGGTGAAATTCTTGGACCGGCGAACCTCCGACTTTCGTTCT^[52](#CIT0052)^aP2AGCGTAGAAGGGGACTTGGTATGGTGGTCGACTTTCCATC^[53](#CIT0053)^AdipoQGGGAGACGCAGGTGTTCTTGCTGAATGCTGAGTGATACATGTAAGC^[54](#CIT0054)^ARCCCATCGACTATTACTTCCCTTACGAGCTCCCAGAGTCAT^[55](#CIT0055)^ANPGCCGGTAGAAGATGAGGTCAGGGCTCCAATCCTGTCAATC^[56](#CIT0056)^BNPATCTGTCGCCGCTGGGAGGTGGATCCGGAAGGCGCTGTC^[56](#CIT0056)^ERαGGCTACGTCAAGTCGATTCCATCTTGTCCAGGACTCGGTG^[57](#CIT0057)^ERβCTCACGTCAGGCACATCAGTTGTGAGCATTCAGCATCTCC^[58](#CIT0058)^LepAGACCATTGTCACCAGGATCAATCCCGGGAATGAAGTCCAAA^[59](#CIT0059)^PKCδACAGAAGAAGCCCACCATGAACTCAGCCTTCCCGTT^[60](#CIT0060)^RenATGCCTCTCTGGGCACTCTTGTCAAACTTGGCCAGCATGA^[61](#CIT0061)^[^2]
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